GWAS studies show that regulatory non-coding variants may play a role in multiple distinct diseases such as cancer [33] and thus the other two intronic variants associated with response (rs2293194 in KCNAB1 and rs4376673 in DFFB) also represent a potential target for further studies. This evidence concerns the gene KCNAB1 and cancer.